Total Payments
$8,447
2024 Payments
$1,300
Companies
35
Transactions
534
Medicare Patients
4,010
Medicare Billing
$512,143
Payment Breakdown by Category
Food & Beverage$8,435 (99.9%)
Education$11.92 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,435 | 533 | 99.9% |
| Education | $11.92 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,907 | 211 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $986.42 | 63 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $918.04 | 78 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $406.21 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $360.31 | 20 | $0 (2024) |
| Mylan Specialty L.P. | $332.42 | 18 | $0 (2024) |
| GENZYME CORPORATION | $309.63 | 12 | $0 (2024) |
| Genentech USA, Inc. | $284.70 | 16 | $0 (2020) |
| Gilead Sciences, Inc. | $243.87 | 17 | $0 (2021) |
| Grifols USA, LLC | $233.21 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,300 | 61 | GlaxoSmithKline, LLC. ($318.64) |
| 2023 | $937.58 | 47 | GlaxoSmithKline, LLC. ($462.26) |
| 2022 | $426.78 | 29 | GlaxoSmithKline, LLC. ($164.37) |
| 2021 | $421.24 | 29 | GlaxoSmithKline, LLC. ($190.31) |
| 2020 | $607.77 | 36 | Sunovion Pharmaceuticals Inc. ($127.54) |
| 2019 | $1,433 | 108 | GlaxoSmithKline, LLC. ($483.47) |
| 2018 | $1,514 | 105 | GlaxoSmithKline, LLC. ($663.02) |
| 2017 | $1,808 | 119 | GlaxoSmithKline, LLC. ($521.07) |
All Payment Transactions
534 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Medical Device | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: SURGERY | ||||||
| 08/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,002 | 1,340 | $278,910 | $108,279 |
| 2022 | 17 | 1,050 | 1,449 | $261,749 | $106,069 |
| 2021 | 16 | 992 | 1,517 | $333,335 | $139,461 |
| 2020 | 16 | 966 | 1,550 | $393,202 | $158,335 |
Total Patients
4,010
Total Services
5,856
Medicare Billing
$512,143
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 93 | 210 | $101,640 | $34,202 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 170 | $35,020 | $15,636 | 44.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 102 | 174 | $29,928 | $15,516 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 229 | $32,060 | $14,313 | 44.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 109 | 151 | $18,120 | $8,906 | 49.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $11,908 | $5,053 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $10,212 | $4,506 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $10,080 | $3,734 | 37.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 86 | 88 | $6,168 | $1,304 | 21.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 12 | $8,232 | $1,167 | 14.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 64 | 65 | $4,910 | $1,095 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,850 | $1,012 | 35.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,387 | $669.44 | 48.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 16 | 16 | $1,360 | $477.82 | 35.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 44 | 44 | $2,834 | $410.64 | 14.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 28 | 28 | $2,201 | $277.39 | 12.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 151 | 355 | $61,060 | $29,222 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 199 | 278 | $38,920 | $17,328 | 44.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 43 | 94 | $45,496 | $16,265 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 126 | $25,956 | $11,443 | 44.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 65 | 67 | $15,343 | $6,957 | 45.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 83 | $9,960 | $4,532 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $9,936 | $4,301 | 43.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $7,392 | $3,379 | 45.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $5,320 | $2,263 | 42.5% |
About Dr. Justin Ardoin, M.D
Dr. Justin Ardoin, M.D is a Pulmonary Disease healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962610360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Ardoin, M.D has received a total of $8,447 in payments from pharmaceutical and medical device companies, with $1,300 received in 2024. These payments were reported across 534 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,435).
As a Medicare-enrolled provider, Ardoin has provided services to 4,010 Medicare beneficiaries, totaling 5,856 services with total Medicare billing of $512,143. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Lafayette, LA
- Active Since 05/18/2007
- Last Updated 01/04/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1962610360
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,563
- DUPIXENT (Biological) $715.84
- NUCALA (Biological) $575.44
- LONHALA MAGNAIR (Drug) $420.98
- ANORO (Drug) $391.42
- BREO (Drug) $349.54
- FASENRA (Drug) $232.59
- FASENRA (Biological) $212.79
- SYMBICORT (Drug) $207.33
- UTIBRON (Drug) $197.48
- XOLAIR (Biological) $177.90
- Xolair (Biological) $158.85
- BEVESPI AEROSPHERE (Drug) $157.38
- Utibron (Drug) $152.09
- TEZSPIRE (Biological) $150.60
- OFEV (Drug) $148.61
- YUPELRI (Drug) $140.26
- Yupelri (Drug) $135.32
- Esbriet (Biological) $125.85
- Da Vinci Surgical System (Device) $123.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lafayette
Mr. Walter Brown, Md, MD
Pulmonary Disease — Payments: $12,452
Pulmonary Disease $12,452
Mr. George Guidry, Md, MD
Pulmonary Disease — Payments: $11,149
Pulmonary Disease $11,149
Timothy Keys, M.d, M.D
Pulmonary Disease — Payments: $10,588
Pulmonary Disease $10,588
Fadi Malek, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $9,325
Pulmonary Disease $9,325
Richard Fei, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $5,969
Pulmonary Disease $5,969
Mehboob Kalani, Md, MD
Pulmonary Disease — Payments: $5,488
Pulmonary Disease $5,488